Synthesis, in vitro biological activity and docking of new analogs of BIM-23052 containing unnatural amino acids
- 26 July 2019
- journal article
- research article
- Published by Springer Nature in Amino Acids
- Vol. 51 (9) , 1247-1257
Abstract
Somatostatin (SST) is an endogenous cyclic tetradecapeptide hormone that exerts multiple biological activities via a family of five receptors. BIM-23052 (DC-23-99) d-Phe-Phe-Phe-d-Trp-Lys-Thr-Phe-Thr-NH2 is a linear SST analog with established in vitro GH-inhibitory activity and high affinity to sstr5, sstr3 and sstr2. The different SSTR subtypes are expressed in different tissues and in some tumor cells. Based on this finding, a series of new analogs of BIM-23052 with expected antitumor activity have been synthesized. The Thr at position 6 in BIM-23052 was replaced by the conformationally hindered Tle, Aib, Ac5c and Ac6c of the new analogs. The peptides were synthesized by standard solid-phase peptide chemistry methods, Fmoc strategy. The cytotoxic effects of the compounds were tested in vitro against a panel of tumor cell lines: HT-29, MDA-MB-23, Hep-G2, HeLa and the normal human diploid cell line Lep-3. All five somatostatin receptor subtypes were modeled and docking was performed to determine the binding affinity of the analogs. The new peptides exhibited different concentration-dependent antiproliferative effect on the tumor cell lines after 24 h of treatment. The compound 3B (Aib6) demonstrated the most pronounced antiproliferative effects on HepG-2 cells with the IC50 = 0.01349 nM. Docking confirmed that all compounds bind well to SST receptors with preference to sstr3 and sstr5, which is most probably the reason for the observed biological effects.Keywords
Funding Information
- Bulgarian National Fund of Scientific Research at the Ministry of Education and Science (grant number DN 19/17, 20.12.2017.)
This publication has 44 references indexed in Scilit:
- Evaluation of biodistribution and safety of adenovirus vector containing MDR1 in miceJournal of Experimental & Clinical Cancer Research, 2010
- MolProbity: all-atom structure validation for macromolecular crystallographyActa Crystallographica Section D Structural Biology, 2009
- Antitumor effects of somatostatinMolecular and Cellular Endocrinology, 2008
- Somatostatin and Its Receptor FamilyFrontiers in Neuroendocrinology, 1999
- The somatostatin receptor familyLife Sciences, 1995
- Contrasting solution conformations of peptides containing α,α‐dialkylated residues with linear and cyclic side chainsBiopolymers, 1995
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993
- Histologic changes in the rat prostate cancer model after treatment with somatostatin analogs and D‐Trp‐6‐LH‐RHThe Prostate, 1988
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Highly active cyclic and bicyclic somatostatin analogues of reduced ring sizeNature, 1979